Yize Mao
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Cancer survivorship and care
- Inflammatory Biomarkers in Disease Prognosis
Papers in
- Oncology 26
- Pancreatic and Hepatic Oncology Research 11
- Cancer Immunotherapy and Biomarkers 5
- Inflammatory Biomarkers in Disease Prognosis 4
-
- Immune cells in cancer 4
- Immunotherapy and Immune Responses 4
- Co-authors
- Zhuowei Liu (6 shared papers)Zikun Ma (6 shared papers)Shengping Li (8 shared papers)Chaobin He (10 shared papers)Shengping Li (16 shared papers)Xin Huang (6 shared papers)Wei Chen (2 shared papers)Zeyu Shuang (6 shared papers)
- Journals
- European Radiology (3 papers)Cancer Medicine (3 papers)Nature Communications (3 papers)Cancer Cell (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yize Mao
38 papers receiving 935 citations
Peers
Comparison fields: 5 of 81
- Oncology 454
- Immunology 133
- Cancer Research 64
- Surgery 152
- Clinical Psychology 72
Countries citing papers authored by Yize Mao
This map shows the geographic impact of Yize Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yize Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yize Mao more than expected).
Fields of papers citing papers by Yize Mao
This network shows the impact of papers produced by Yize Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yize Mao. The network helps show where Yize Mao may publish in the future.
Co-authors
The 25 scholars most cited alongside Yize Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 207 | |
| 2 | 2022 | 159 | |
| 3 | 2016 | 73 | |
| 4 | 2020 | 62 | |
| 5 | 2018 | 42 | |
| 6 | 2023 | 36 | |
| 7 | 2020 | 32 | |
| 8 | 2018 | 32 | |
| 9 | 2018 | 28 | |
| 10 | 2017 | 24 | |
| 11 | 2020 | 22 | |
| 12 | 2017 | 22 | |
| 13 | 2024 | 21 | |
| 14 | 2023 | 18 | |
| 15 | 2018 | 16 | |
| 16 | 2020 | 16 | |
| 17 | 2020 | 16 | |
| 18 | 2016 | 15 | |
| 19 | 2018 | 15 | |
| 20 | 2022 | 13 |
About Yize Mao
Yize Mao is a scholar working on Oncology, Immunology, Surgery, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 43 papers that have together received 946 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immune cells in cancer (4 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), Immunotherapy and Immune Responses (4 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Oncology (454 citations), Immunology (133 citations), Cancer Research (64 citations), Surgery (152 citations) and Clinical Psychology (72 citations). Yize Mao has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhuowei Liu, Zikun Ma, Shengping Li, Chaobin He, Shengping Li, Xin Huang, Wei Chen, Zeyu Shuang, Guo‐He Lin and Runsen Chen. Their work appears in journals such as European Radiology, Cancer Medicine, Nature Communications, Cancer Cell and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.